Related Experiment Video
Updated: Oct 14, 2025

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
Mortality probabilities after revascularization and medical therapy in CAD patients under 60 years old: a
Mohammad Afrouzi1, Farbod Ebadi Fard Azar2, Ali Aboutorabi1
1Department of Health Economics, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
Insights
This meta-analysis found that coronary artery bypass graft (CABG) and percutaneous coronary intervention (PCI) have lower mortality rates than medical therapy (MT) in patients under 60. These findings are crucial for cost-effectiveness evaluations in coronary artery disease management.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Health Economics
Background:
- Coronary artery disease (CAD) management in patients under 60 requires understanding treatment efficacy.
- Estimating death probabilities is vital for economic evaluations of interventions like coronary artery bypass graft (CABG), percutaneous coronary intervention (PCI), and medical therapy (MT).
Purpose of the Study:
- To estimate and compare mortality probabilities associated with CABG, PCI, and MT in patients younger than 60 years.
- To provide data for cost-effectiveness analyses of CAD treatments in this demographic.
Main Methods:
- Systematic literature search of PubMed, Embase, Cochrane Library, and Web of Science up to January 2021.
- Meta-analyses conducted using Comprehensive Meta-Analysis and Review Manager.
- Inclusion of nine studies with 16,410 patients (mean age 51.2 ± 6 years) and a mean follow-up of 3.7 ± 2 years.
Main Results:
- Overall mortality rates after a mean follow-up were: CABG 3.6%, PCI 4.3%, and MT 9.7%.
- In equal follow-up periods, CABG (3.5%) and PCI (4.2%) showed significantly lower mortality compared to MT (9.5%).
- Mortality after PCI in STEMI patients was higher in the elderly versus young and lower in men versus women.
Conclusions:
- CABG and PCI demonstrate lower mortality probabilities compared to MT in patients under 60 with CAD.
- The estimated mortality rates are critical inputs for economic evaluations to determine the cost-effectiveness of these interventions.
- Further analysis revealed demographic influences on PCI mortality in specific acute coronary syndrome presentations.
Abstract:
To estimate death probabilities after coronary artery bypass graft (CABG), percutaneous coronary intervention (PCI), and medical therapy (MT) in patients under 60 years old. We conducted a search systematic on PubMed, Embase, Cochrane Library, and Web of Science up to January 2021. The study included three parts. In the probabilities part (A), Comprehensive Meta-Analysis, and in the comparison parts (B and C), Review Manager was used in conducting meta-analyses. Nine studies consisting of 16,410 people with a mean age of 51.2 ± 6 years were included in the meta-analysis. Over a mean follow-up of 3.7 ± 2 years, overall mortality after CABG, PCI and MT was 3.6% (95% CI 0.021-0.061), 4.3% (95% CI 0.023-0.080) and 9.7% (95% CI 0.036-0.235), respectively. The length of follow-up periods was almost the same and did not differ much (p = 0.19). In Part B (without adjustment of baseline characteristics), 495 (4.0%) of 12,198 patients assigned to CABG died compared with 748 (4.5%) of 16,458 patients assigned to PCI (risk ratio [RR]: 0.77, 95% CI 0.50-1.20; p = 0.25). Seventy-four (3.5%) of 2120 patients assigned to CABG and 68 (4.2%) of 1621 patients assigned to PCI died compared with 103 (9.5%) of 1093 patients assigned to MT in equal follow-up periods (CABG-MT: RR 0.34; 95% CI 0.23-0.51; p < 0.002) (PCI-MT: RR 0.40; 95% CI 0.30-0.53; p = 0.02). In Part C, overall mortality after PCI in PACD patients with STEMI was higher in elderly versus young (RR 2.64; 95% CI 2.11-3.30) and is lower in men versus women (RR 0.61; 95% CI 0.44-0.83). Mortality probabilities obtained are one of the most important factors of effectiveness in the economic evaluation studies; these rates can be used to determine the cost-effectiveness of procedures in CAD patients aged < 60 years.
More Related Videos
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis III: Management
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease II: Pathophysiology